Physician profile
Michael James Kushner
NPI 1417911223
$504.84
in general payments reported to CMS, 2019-2025
15 companies · $24.15 in 2025
The $24.15 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $79.27 · 2025: $24.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $87.06 | 2019 | |
| Ferring Pharmaceuticals INC. | $72.09 | 2019-2020 | |
| Emd Serono, INC. | $49.48 | 2019 | |
| Pacira Therapeutics, INC. | $48.77 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $41.80 | 2019 | |
| Endo Pharmaceuticals INC. | $38.79 | 2019 | |
| Adamas Pharmaceuticals, INC. | $25.15 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $24.28 | 2019 | |
| Pfizer INC. | $24.15 | 2025 | |
| Hitachi Healthcare Americas Corp. | $19.81 | 2020 | |
| Assertio Therapeutics, INC. | $18.71 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.14 | 2020 | |
| Kci USA, INC. | $14.12 | 2019 | |
| Ge Healthcare | $13.42 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kushner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.